Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Acta Neurochir (Wien). 2024 Nov 4;166(1):437. doi: 10.1007/s00701-024-06331-4.
This study investigated the interfractional volume changes of large (≥ 10 cm) brain metastases (BMs) during fractionated gamma knife radiosurgery (FGKRS) to assess its predictive value for tumor control outcomes.
The patients who underwent FGKRS for large BMs between January 2017 and December 2022 in our center were reviewed. The interfractional volume change was defined as the disparity in tumor volume (TV) measured between the magnetic resonance images acquired on the first treatment day and those obtained after 2 or 3 fractions during the course of FGKRS.
A total of 73 lesions in 70 patients with various primary pathologies were included. Over a median follow-up period of 11 months (range 1-77), the tumor control rate was 63%. Initial TV (cm) was associated with progression free survival (PFS) and overall survival (OS) in both univariate and multivariate analyses (p = 0.01). Interfractional TV changes revealed an increase in 13 (17.8%) lesions, no change in 14 (19.2%) lesions, and a decrease in 46 (63.0%) lesions, with a mean volume reduction of 5% ± 0.12. Three cut-offs (5%, 10% and 15% volume decrement) were established and patients were divided into two groups based on each reference point. However, there were no significant differences in PFS and OS between the two groups, irrespective of the chosen cut-off value used.
Interfractional volume changes of large BMs were not found to be associated with tumor control outcomes. Neither significant interfractional volume reduction nor significant volume increase necessarily predicts the tumor control, making early close monitoring essential after FGKRS.
本研究旨在探讨分次伽玛刀放射外科治疗(FGKRS)中大型(≥10cm)脑转移瘤(BM)的分次间体积变化,以评估其对肿瘤控制结果的预测价值。
回顾性分析了 2017 年 1 月至 2022 年 12 月期间在我中心接受 FGKRS 治疗的大型 BM 患者。定义分次间体积变化为治疗第一天获得的磁共振图像上测量的肿瘤体积(TV)与 FGKRS 过程中获得的第 2 或 3 次分割后获得的 TV 之间的差异。
共纳入了 70 名患者的 73 个病灶,这些患者具有不同的原发疾病。在中位数为 11 个月(范围 1-77 个月)的随访期间,肿瘤控制率为 63%。在单因素和多因素分析中,初始 TV(cm)与无进展生存期(PFS)和总生存期(OS)相关(p=0.01)。分次间 TV 变化显示 13 个(17.8%)病灶增大,14 个(19.2%)病灶无变化,46 个(63.0%)病灶减小,平均体积减少 5%±0.12。确定了 3 个截断值(5%、10%和 15%的体积减少),并根据每个参考点将患者分为两组。然而,无论选择的截断值如何,两组之间的 PFS 和 OS 均无显著差异。
大型 BM 的分次间体积变化与肿瘤控制结果无关。分次间体积显著减少或显著增加并不一定预示肿瘤控制,因此 FGKRS 后早期密切监测至关重要。